This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Reference

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Committee on Safety of Medicines (1996). Oesophageal reactions with alendronate sodium (Fosamax). Current Problems in Pharmacovigilance, 22, 5.

Liberman UA et al (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. NEJM, 333, 1437-43.

Osteoporosis Clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. Royal College of Physicians, Bone and Tooth Society of Great Britain July 2000

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.